Nitrosylcobalamin Potentiates the Anti-Neoplastic Effects of Chemotherapeutic Agents via Suppression of Survival Signaling
2007

Nitrosylcobalamin Enhances Chemotherapy Effects

Sample size: 13 publication Evidence: high

Author Information

Author(s): Bauer Joseph A., Lupica Joseph A., Schmidt Heidi, Morrison Bei H., Haney Rebecca M., Masci Rhonda K., Lee Rebecca M., DiDonato Joseph A., Lindner Daniel J.

Primary Institution: The Cleveland Clinic Foundation

Hypothesis

Can nitrosylcobalamin (NO-Cbl) enhance the anti-tumor effects of chemotherapeutic agents?

Conclusion

NO-Cbl can enhance the effectiveness of chemotherapy by inhibiting survival signaling pathways.

Supporting Evidence

  • 78% of the drug combinations tested showed a synergistic anti-proliferative effect.
  • NO-Cbl pre-treatment decreased NF-κB DNA binding activity.
  • NO-Cbl inhibited IκB kinase activity and AKT activation.
  • Combination treatment resulted in a 99.01% reduction in tumor volume in vivo.

Takeaway

This study shows that a special form of vitamin B12 can help cancer treatments work better by stopping cancer cells from surviving.

Methodology

The study used anti-proliferative assays, EMSA, immunoblot analysis, and kinase assays to evaluate the effects of NO-Cbl with various chemotherapeutic agents.

Statistical Information

P-Value

0.000012

Confidence Interval

95% CI = 60.90% to 69.81%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001313

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication